Conjoint analysis to understand preferences of patients with multiple sclerosis for disease-modifying therapy attributes in Spain: a cross-sectional observational study

Conclusions Patient DMT preferences were mainly driven by risk minimisation, route of administration and treatment schedule. The risk–benefit spectrum of available DMT for MS is becoming increasingly complicated. Understanding which treatment characteristics are meaningful to patients may help to tailor information for them and facilitate shared decision-making in clinical practice.

http://bmjopen.bmj.com/cgi/content/short/7/3/e014433?rss=1

Source: BMJ Open - March 7, 2017 Category: Journals (General) Authors: Arroyo, R., Sempere, A. P., Ruiz-Beato, E., Prefasi, D., Carreno, A., Roset, M., Maurino, J. Tags: Open access, Neurology, Patient-centred medicine Research Source Type: research